Omar N. Lweno

In the News

IHI team engages with top brass at SERI

The IHI team (right) led by Dr. Honorati Masanja (not seen on the photo) meets with SERI officials (left row) during a stakeholder engagement meeting in Bern last week. PHOTO/COURTESY …

Health professionals learn “One Health” approach

Dr. Ally Olotu stresses a point when he addressed participants and invited guests during the opening ceremony. PHOTO/IHIcoms (Bagamoyo, Aprili 5 2019) Health professionals from Zoonotic disease risk areas of …

Recent Projects

Calcium supplementation on pregnant women

Project summary This is a trial-based study funded by the Bill and Melinda Gates Foundation. It intends to generate evidence for decision-making on the potential non-inferiority of a lower dose …

Sustainable, Healthy, Learning Cities and Neighbourhoods

The Sustainable, Healthy, Learning Cities and Neighbourhoods is an exciting project in which IHI works with a consortium of partners from Asia and Africa to 1) develop capacity for improved …

Omar N. Lweno

Research Scientist

Dr. Omar N. Lweno has over 10 years of experience in clinical patient care and supervision of health services. He has also served as coordinator of Care and Treatment Clinic for People living with HIV/AIDS which was technically supported by the Elizabeth Glaser Paediatric HIV Foundation  (EGPAF). He has served as a study clinician in a number of drug trials evaluating Artemisinin-based combination therapies (ACTs),  and Bioequivalence studies. His research experience include malaria vaccine trials from phase 1 trials of Controlled Human Malaria Infection by PfSPZ- Sporozoite challenge and p27A antigen to phase 3 multicentre trial of the RTS,s candidate malaria vaccine as Safety Clinician. He has worked as Co-investigator in the IDEA-Tz project part of the international consortium examining the immunological interaction between Helminths/Malaria and Helminths/HIV.  He also served as Co-investigator in the recently completed “Human monoclonal antibodies study to aid antigen discovery and prioritization for malaria vaccine development” among pregnant women with malaria  in collaboration with  the National Institute of Medical Research (NIMR) and University of Cape Town. Dr. Lweno is the Principal Investigator of a phase 3 clinical trial comparing Intravenous Ferric Carboxymaltose (Ferinject) to Oral iron in the treatment of iron deficiency anemia at delivery in Tanzania(ClinicalTrials.govID: NCT02541708). This is a collaborative study between Ifakara Health Institute and Swiss Tropical and Public Health Institute (Swiss TPH).

View Dr. Lweno’s Research Interests and Publications


Evaluation of intravenous iron supplementation compared to oral supplementation among women with iron-deficient anemia

© Ifakara Health Institute (IHI), 2016